AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE SAFETY OF RIVIPANSEL (GMI-1070) IN THE TREATMENT OF ONE OR MORE VASOOCCLUSIVE CRISES IN HOSPITALIZED SUBJECTS WITH SICKLE CELL DISEASE
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Pfizer, Inc.
Start Date
March 1, 2016
End Date
December 31, 2021
Administered By
Medicine, Hematology
Awarded By
Pfizer, Inc.
Start Date
March 1, 2016
End Date
December 31, 2021